SE9901634D0 - Treatment of myocardial infarction with a substance related to the growth hormone axis - Google Patents

Treatment of myocardial infarction with a substance related to the growth hormone axis

Info

Publication number
SE9901634D0
SE9901634D0 SE9901634A SE9901634A SE9901634D0 SE 9901634 D0 SE9901634 D0 SE 9901634D0 SE 9901634 A SE9901634 A SE 9901634A SE 9901634 A SE9901634 A SE 9901634A SE 9901634 D0 SE9901634 D0 SE 9901634D0
Authority
SE
Sweden
Prior art keywords
growth hormone
treatment
myocardial infarction
substance related
axis
Prior art date
Application number
SE9901634A
Other languages
English (en)
Inventor
Joergen Isgaard
Elmir Omerovic
Entela Bollano
Bengt-Aake Bengtsson
Original Assignee
Sahltech Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sahltech Ab filed Critical Sahltech Ab
Priority to SE9901634A priority Critical patent/SE9901634D0/sv
Publication of SE9901634D0 publication Critical patent/SE9901634D0/sv
Priority to AU47908/00A priority patent/AU4790800A/en
Priority to PCT/SE2000/000844 priority patent/WO2000067770A1/en
Priority to EP00930008A priority patent/EP1173190A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/30—Insulin-like growth factors (Somatomedins), e.g. IGF-1, IGF-2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/25—Growth hormone-releasing factor [GH-RF] (Somatoliberin)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/27—Growth hormone [GH] (Somatotropin)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
SE9901634A 1999-05-05 1999-05-05 Treatment of myocardial infarction with a substance related to the growth hormone axis SE9901634D0 (sv)

Priority Applications (4)

Application Number Priority Date Filing Date Title
SE9901634A SE9901634D0 (sv) 1999-05-05 1999-05-05 Treatment of myocardial infarction with a substance related to the growth hormone axis
AU47908/00A AU4790800A (en) 1999-05-05 2000-05-03 Treatment of acute myocardial infarction with a substance related to the growth hormone axis
PCT/SE2000/000844 WO2000067770A1 (en) 1999-05-05 2000-05-03 Treatment of acute myocardial infarction with a substance related to the growth hormone axis
EP00930008A EP1173190A1 (en) 1999-05-05 2000-05-03 Treatment of acute myocardial infarction with a substance related to the growth hormone axis

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9901634A SE9901634D0 (sv) 1999-05-05 1999-05-05 Treatment of myocardial infarction with a substance related to the growth hormone axis

Publications (1)

Publication Number Publication Date
SE9901634D0 true SE9901634D0 (sv) 1999-05-05

Family

ID=20415485

Family Applications (1)

Application Number Title Priority Date Filing Date
SE9901634A SE9901634D0 (sv) 1999-05-05 1999-05-05 Treatment of myocardial infarction with a substance related to the growth hormone axis

Country Status (4)

Country Link
EP (1) EP1173190A1 (sv)
AU (1) AU4790800A (sv)
SE (1) SE9901634D0 (sv)
WO (1) WO2000067770A1 (sv)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1536817A1 (en) * 2002-08-23 2005-06-08 Gestion Univalor Société en Commandite Growth hormone-releasing peptides in the treatment of prevention of atherosclerosis and hypercholesterolemia
EP1529533A1 (en) * 2003-11-06 2005-05-11 Sahltech I Göteborg AB Use of GH secretagogues in hypoxic-ischemic brain injury

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9100099D0 (sv) * 1991-01-11 1991-01-11 Kabi Pharmacia Ab Use of growth factor
US5610134A (en) * 1994-04-15 1997-03-11 Genentech, Inc. Treatment of congestive heart failure
AU737065B2 (en) * 1997-07-04 2001-08-09 Pharmacia Ab Use of growth hormone in compositions for treating insulin resistance in the heart and for enhancing protein kinase B (PKB) activity

Also Published As

Publication number Publication date
EP1173190A1 (en) 2002-01-23
AU4790800A (en) 2000-11-21
WO2000067770A1 (en) 2000-11-16

Similar Documents

Publication Publication Date Title
HUP9901246A2 (hu) Növekedési hormon kiválasztását elősegítő vegyületek
WO2002015903A3 (de) Neue pharmazeutische zusammensetzung zur verabreichung von n-0923
DE60043305D1 (de) Pharmazeutische zubereitungen zur behandlung von insulinresitenz
GEP20043314B (en) Pharmaceutical Composition Comprising Entacapone, Levodopa, and Carbidopa
ATE235895T1 (de) Arzneistoff-abgabesystem enthaltend eine festgepackte, feste arzneistoffbasis
HUP0003173A2 (hu) A GLP-1 vagy analógjainak alkalmazása szívizominfarktus kezelésére használható gyógyszerkészítmények előállítására
EP1186293A3 (en) Intermittent administration of a growth hormone secretagogue
HUP0203506A2 (hu) Terápiás ágensként használható módosított peptidek
CY1107051T1 (el) Αντι-διηθητικα και αντι-αγγειογενετικα θραυσματα ουροκινασης και η χρηση τους
ATE401892T1 (de) Verwendung von pharmazeutischen zubereitungen enthaltend oxcarbazepin im nüchternzustand
CA2326517A1 (en) New galenic preparations of meloxicam for oral administration
UA41446C2 (uk) Застосування фумагілолу та його похідних для одержання ліків, призначених для боротьби з кишковими інфекціями, та фармацевтична композиція на їх основі
RU93036959A (ru) Свободно растворимый лекарственный препарат с замедленным действием биологически активных веществ, назначенный для приема внутрь, способ его производства
NZ320237A (en) Stable pharmaceutical forms of administration containing parathormone
HUP0003840A2 (hu) Szabályozott hatóanyagleadású gyógyászati készítmények
RU2004114865A (ru) Композиция и способ лечения диабета
MY129946A (en) Compound with gastric acid inhibitory effect and process for its preparation.
JP2002530353A5 (sv)
SE9901634D0 (sv) Treatment of myocardial infarction with a substance related to the growth hormone axis
DE50000864D1 (de) Verwendung von desoxypeganin zur behandlung von drogenabhängigkeit
EA200200801A1 (ru) Применение фолликулостимулирующего гормона (fsh) для лечения бесплодия
DE50010973D1 (de) Pharmazeutische zusammensetzung, enthaltend desoxypeganin zur behandlung des alkoholismus
EA199900438A1 (ru) Препарат местного применения для введения пептидных лекарственных средств в живые организмы
TR200202110T2 (tr) "5-[{6-(2-Flüore benzil) oksi-2-naftil}metil]-2,4-tiyazolidin dion kristalleri"
JP2002529515A5 (sv)